These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2094677)

  • 61. [Toxicity of antitubercular agents for the liver].
    Dölle W
    Dtsch Med Wochenschr; 1973 Jan; 98(2):74. PubMed ID: 4683834
    [No Abstract]   [Full Text] [Related]  

  • 62. Chemotherapy of tuberculosis.
    Pinsker KL; Koerner SK
    Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Urinary bladder tuberculosis and Bacillus Calmette-Guérin instillation: reduced efficacy of bisoprolol in hypertension].
    Drechsler A; Kirch W
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1968-70. PubMed ID: 20922637
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Side effects of antitubercular drugs leading to discontinuation of drug therapy].
    Bergan S; Laake K; Bjartveit K
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):279-82. PubMed ID: 7385151
    [No Abstract]   [Full Text] [Related]  

  • 65. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)].
    May P; König K
    Z Urol Nephrol; 1969; 62(9):657-62. PubMed ID: 5408556
    [No Abstract]   [Full Text] [Related]  

  • 67. First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
    Cao J; Mi Y; Shi C; Bian Y; Huang C; Ye Z; Liu L; Miao L
    Biochem Biophys Res Commun; 2018 Mar; 497(2):485-491. PubMed ID: 29454961
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Side effects of tuberculostatics (author's transl)].
    Favez G; Wiser H
    Munch Med Wochenschr; 1973 Sep; 115(39):1685-90. PubMed ID: 4801051
    [No Abstract]   [Full Text] [Related]  

  • 69. Isoniazid and rifampicin rarely cause acute pancreatitis in patients with tuberculosis.
    Chan TY
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):109. PubMed ID: 10082175
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of tuberculous praevesical ureteral strictures (author's transl)].
    May P; Schindler E
    Urologe A; 1974 Jan; 13(1):1-5. PubMed ID: 4856813
    [No Abstract]   [Full Text] [Related]  

  • 72. Antimycobacterial therapy.
    Van Scoy RE; Wilkowske CJ
    Mayo Clin Proc; 1999 Oct; 74(10):1038-48. PubMed ID: 10918872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Allergy to antitubercular agents; with special reference to new drugs].
    Mühlberger F
    Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096
    [No Abstract]   [Full Text] [Related]  

  • 74. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy.
    Aditya NP; Patankar S; Madhusudhan B
    Parasitol Res; 2010 May; 106(6):1481-4. PubMed ID: 20165870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Monitoring of antitubercular treatments. Value of the determination of serum gamma-glutamyl transpeptidase (gamma-GT)].
    Homasson JP; Salignac P; Bonniot JP; Parent G; Angebault M
    Nouv Presse Med; 1977 Mar; 6(10):858. PubMed ID: 15237
    [No Abstract]   [Full Text] [Related]  

  • 78. Ethambutol in pregnancy: observations on embryogenesis.
    Lewit T; Nebel L; Terracina S; Karman S
    Chest; 1974 Jul; 66(1):25-6. PubMed ID: 4210566
    [No Abstract]   [Full Text] [Related]  

  • 79. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
    Kocabay G; Erelel M; Tutkun IT; Ecder T
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1418-9. PubMed ID: 17171829
    [No Abstract]   [Full Text] [Related]  

  • 80. Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
    Macnab MF; Bohmer PD; Seager JR
    S Afr Med J; 1994 Jun; 84(6):325-8. PubMed ID: 7740377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.